Tamoxifen Prediction Study in Patients With ER+ Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: ER+ Breast Cancer
Interventions: DRUG: Tamoxifen
Sponsor: Erasmus Medical Center